rcep 2 (810 by 450)join 2

Unions say TPP destroys jobs, deepens inequality, increases health costs

18 October 2016: Unions called for the TPP to be rejected at a parliamentary hearing on Monday, citing an independent analysis showing it could destroy 39,000 jobs by 2025.

ACTU's director of policy Belinda Tkalcevic said: The TPP is a toxic combination of more power to multinationals ahead of democracy and globalisation ahead of Australian workers.

Key business group whacks the TPP: Peter Martin

18 October 2016: Australia's biggest business organisation was highly critical of the TPP at a parliamentary hearing yesterday. Rather than facilitate trade, the ACCI expressed concerns that it could actually make trade more complex, adding to the noodle bowl of complex trading terms that business has to navigate. This would further complicate compliance and costs for business. Read the full article here.

Public health groups condemn stronger medicine monopolies as RCEP talks continue

MEDIA RELEASE, 18 October 2016: Ninety-four public health and other community groups from 12 countries have condemned proposals for the inclusion of stronger medicine monopolies in the Regional Comprehensive Economic Partnership (RCEP) as secret negotiations continue this week in China.

The open letter to RCEP governments is available here.

No winners in El Salvador vs Pacific Rim case

October 15, 2016: After seven years of arbitration the ISDS case brought by mining company Pacific Rim against El Salvador has been found without merit, meaning the country will not have to pay the $250 million sought by the company.

However, there are no real winners. El Salvador had to spend over $12 million to defend the case, brought despite the mining company never fulfilling the legal requirements for a mining license.  

RCEP could block access to generic drugs: MSF

12 October 2016: Intellectual property provisions in the China-led RCEP regional trade deal could block access to life-saving drugs for millions in Africa and Asia, warns Medecins Sans Frontieres (MSF) regional representative Dr Maria Guevara.

"The enforcement provisions attempt to prevent the flow of generic medicines from producer to patient, thereby providing a blank cheque for abuse," she writes.